Analytical and
In Vivo Imaging
Services

Maximize the Value of your Biodistribution,

Neuroscience and Oncology Studies

Take your Preclinical Discovery Research to New Frontiers

As experts in preclinical discovery research, MediLumine offers premier CRO research services to premier biotech and pharmaceutical companies across the world. Whether it be assessing the effectiveness of an oncology therapeutic, measuring kinetics of drug diffusion through blood brain barrier or quantifying biodistribtion, our tested framework across various imaging modalities (MRI, PET, CT, Optical Bioluminescence, SWIR) and quality assurance policies have been trusted for over a decade, helping hundreds of scientists rapidly get answers to their questions.

Services Provided

Benefits of Working with MediLumine

Schedule a call with our application scientists so that we can determine the best route (analytical, imaging or both) to get you the most significant quantitative results and answers to your questions related to your preclinical discovery research.

We guarantee the employment of systemic methodologies geared towards objective analysis of diverse datasets, allowing you to draw data-driven interpretations.

Scoring Lung Fibrosis
Generate Quantitative Tissue/Air/Density Maps for Scoring Lung Fibrosis
Powerful Segmentation/Quantification
Quantify tracer uptake in various organs with ease
Machine Learning
Use machine learning and semi-automated tools for quantifying tracer uptake
Managed by Carbon Digital